In the published article, there was an error in affiliation 1. Instead of “1Department of Neurosurgery, School of Medicine, Shanghai Tenth People’s Hospital, Tongji University, Shanghai, China”, it should be “Department of Neurosurgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China” as above.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
anaplastic astrocytoma, chemotherapy, SEER, heart disease-related death, cardio-oncology
Citation
Lin Q, Bao J-H, Xue F, Qin J-J, Chen Z, Chen Z-R, Li C, Yan Y-X, Fu J, Shen Z-L and Chen X-Z (2022) Corrigendum: The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: A SEER population-based analysis. Front. Oncol. 12:995352. doi: 10.3389/fonc.2022.995352
Received
15 July 2022
Accepted
19 July 2022
Published
04 August 2022
Approved by
Frontiers Editorial Office, Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Lin, Bao, Xue, Qin, Chen, Chen, Li, Yan, Fu, Shen and Chen.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xian-Zhen Chen, Chenchenxianzheny@126.com; Zhao-Li Shen, Shenleelies@sina.com; Jin Fu, fujin@tongji.edu.cn
† These authors have contributed equally to this work and share first authorship
‡ These authors have contributed equally to this work
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.